Drug Shortage Report for CEFOXITIN FOR INJECTION
Report ID | 229942 |
Drug Identification Number | 02128195 |
Brand name | CEFOXITIN FOR INJECTION |
Common or Proper name | CEFOXITIN INJECTION 2 GRAM |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | CEFOXITIN |
Strength(s) | 2G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 10pk |
ATC code | J01DC |
ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-06-06 |
Estimated end date | 2025-04-30 |
Actual end date | 2025-04-07 |
Shortage status | Resolved |
Updated date | 2025-04-08 |
Company comments | Product now available |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v21 | 2025-04-08 | English | Compare |
v20 | 2025-04-07 | French | Compare |
v19 | 2025-04-07 | English | Compare |
v18 | 2025-04-02 | French | Compare |
v17 | 2025-04-02 | English | Compare |
v16 | 2025-03-20 | French | Compare |
v15 | 2025-03-20 | English | Compare |
v14 | 2024-11-14 | French | Compare |
v13 | 2024-11-14 | English | Compare |
v12 | 2024-10-24 | French | Compare |
v11 | 2024-10-24 | English | Compare |
v10 | 2024-09-19 | French | Compare |
v9 | 2024-09-19 | English | Compare |
v8 | 2024-08-30 | French | Compare |
v7 | 2024-08-30 | English | Compare |
v6 | 2024-06-20 | French | Compare |
v5 | 2024-06-20 | English | Compare |
v4 | 2024-06-13 | French | Compare |
v3 | 2024-06-13 | English | Compare |
v2 | 2024-06-07 | French | Compare |